Form 8-K - Current report:
SEC Accession No. 0001213900-24-084456
Filing Date
2024-10-02
Accepted
2024-10-02 12:30:33
Documents
15
Period of Report
2024-09-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0216422-8k_klotho.htm   iXBRL 8-K 28268
2 PRESS RELEASE DATED SEPTEMBER 30, 2024 ea021642201ex99-1_klotho.htm EX-99.1 11012
  Complete submission text file 0001213900-24-084456.txt   265820

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE kltow-20240924.xsd EX-101.SCH 3502
4 XBRL DEFINITION FILE kltow-20240924_def.xml EX-101.DEF 26963
5 XBRL LABEL FILE kltow-20240924_lab.xml EX-101.LAB 37106
6 XBRL PRESENTATION FILE kltow-20240924_pre.xml EX-101.PRE 25584
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0216422-8k_klotho_htm.xml XML 5653
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241346021
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)